We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Vitamin B-12 and neural tube defects: the Canadian experience.
- Authors
Thompson, Miles D; Cole, David E C; Ray, Joel G
- Abstract
Although early epidemiologic studies showed a protective effect of adequate maternal folic acid (FA) status against neural tube defects (NTDs), the role of adequate vitamin B-12 nutrition in the putative reduction of NTD frequency has remained uncertain. Evaluating vitamin B-12 status was complicated by the need to control for altered FA status after fortification in Canada. More recent studies have made use of better biomarkers of vitamin B-12 status, including methylmalonic acid and holotranscobalamin (holoTC). HoloTC provides a useful measure of vitamin B-12 status because it represents the bioavailable fraction of circulating vitamin B-12. By assessing bioavailable vitamin B-12 status in a large Canadian cohort accrued before and after FA fortification, we found a 3-fold increase in the risk of NTDs in mothers who had vitamin B-12 status in the lower quartile, regardless of FA fortification. Our work suggests that vitamin B-12 fortification, analogous to the FA fortification program, may reduce NTDs more than FA fortification alone. A multicenter randomized controlled trial comparing periconceptional vitamin B-12 in combination with FA against FA alone is warranted.
- Publication
The American journal of clinical nutrition, 2009, Vol 89, Issue 2, p697S
- ISSN
1938-3207
- Publication type
Journal Article
- DOI
10.3945/ajcn.2008.26947B